Clinical comparison of new monoclonal antibody-based nephelometric assays for free light chain kappa and lambda to polyclonal antibody-based assays and immunofixation electrophoresis

Clinical Chemistry and Laboratory Medicine

Volumn 50, Issue 3, 2012, Pages 489-495

  Hoedemakers, Rein M J ^a   Pruijt, Johannes F M ^a   Hol, Suzanne ^b   Teunissen, Elisa ^b   Martens, Henk ^a   Stam, Peter ^b   Melsert, Roel ^b   Te Velthuis, Henk ^b,c  

^a JEROEN BOSCH HOSPITAL   (Netherlands)

^b CENTRAL LABORATORY   (Netherlands)

^c SANQUIN RESEARCH   (Netherlands)

Author keywords

free light chains; immunofixation electrophoresis; method comparison; monoclonal gammopathy; nephelometry; sensitivity; specificity

Indexed keywords

IMMUNOGLOBULIN KAPPA CHAIN; IMMUNOGLOBULIN LAMBDA CHAIN; MONOCLONAL ANTIBODY; POLYCLONAL ANTIBODY;

ARTICLE; CONTROLLED STUDY; ELECTROPHORESIS; HUMAN; IMMUNOASSAY; IMMUNOFIXATION ELECTROPHORESIS; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MONOCLONAL IMMUNOGLOBULINEMIA; NEPHELOMETRY; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY;

ANTIBODIES, MONOCLONAL; ELECTROPHORESIS; HOSPITALS; HUMANS; IMMUNOGLOBULIN KAPPA-CHAINS; IMMUNOGLOBULIN LAMBDA-CHAINS; NEPHELOMETRY AND TURBIDIMETRY; PARAPROTEINEMIAS; SENSITIVITY AND SPECIFICITY; SEROLOGIC TESTS;

EID: 84860478665     PISSN: 14346621     EISSN: 14374331     Source Type: Journal    
DOI: 10.1515/cclm.2011.793     Document Type: Article

References (18)

1. Katzmann JA, Abraham RS, Dispenzieri A, Lust JA, Kyle RA. Diagnostic performance of quantitative and free light chain assays in clinical practice. Clin Chem 2005;51:878-81. (Pubitemid 40577925)
2. Lachmann HJ, Gallimore R, Gillmore JD, Carr-Smith HD, Bradwell AR, Pepys MB, et al. Outcome in systemic AL amyloidosis in relation to changes in concentration of circulating free immunoglobulin light chains following chemotherapy. Br J Haematol 2003;122:78-84. (Pubitemid 36819341)
3. Morris KL, Tate JR, Gill D, Kennedy G, Wellwood J, Marlton P, et al. Diagnostic and prognostic utility of the serum free light chain assay in patients with AL amyloidosis. Intern Med J 2007;37:456-63. (Pubitemid 46855081)
4. Dispenzieri A, Katzmann JA, Kyle RA, Larson DR, Melton LJ, III, Colby CL, et al. Prevalence and risk of progression of light-chain monoclonal gammopathy of undetermined signifi - cance: a retrospective population-based cohort study. Lancet 2010;375:1721-8.
5. Bradwell AR, Carr-Smith HD, Mead GP, Tang LX, Showell PJ, Drayson MT, et al. Highly sensitive, automated immunoassay for immunoglobulin free light chains in serum and urine. Clin Chem 2001;47:673-80. (Pubitemid 32275810)
6. Dispenzieri A, Kyle R, Merlini G, Miguel JS, Ludwig H, Hajek R, et al. International Myeloma Working Group guidelines for serum-free light chain analysis in multiple myeloma and related disorders. Leukemia 2009;23:215-24.
7. Katzmann JA, Kyle RA, Benson J, Larson DR, Snyder MR, Lust JA, et al. Screening panels for detection of monoclonal gammopathies. Clin Chem 2009;55:1517-22.
8. Tate JR, Mollee P, Dimeski G, Carter AC, Gill D. Analytical performance of serum free light-chain assay during monitoring of patients with monoclonal light-chain diseases. Clin Chim Acta 2007;376:30-6. (Pubitemid 44880976)
9. Briand PY, Decaux O, Caillon H, Grosbois B, Le TA, Guenet L. Analytical performance of the serum free light chain assay. Clin Chem Lab Med 2010;48:73-9.
10. te Velthuis H, Knop I, tam P, van den Broek M, Klaasse Bos H, Hol S, et al. N Latex FLC-new monoclonal high performance assays for the determination of free light chain and ?. Clin Chem Lab Med 2011;49:1323-32.
11. Landis JR, Koch GG. The measurement of observer agreement for categorical data. Biometrics 1977;33:159-74. (Pubitemid 8054849)
12. Katzmann JA, Clark RJ, Abraham RS, Bryant S, Lymp JF, Bradwell AR, et al. Serum reference intervals and diagnostic ranges for free and free immunoglobulin light chains: relative sensitivity for detection of monoclonal light chains. Clin Chem 2002;48:1437-44. (Pubitemid 34925779)
13. de Kat Angelino CM, Raymakers R, Teunesen MA, Jacobs JF, Klasen IS. Overestimation of serum free light chain concentration by immunonephelometry. Clin Chem 2010;56:1188-90.
14. Mead GP, Carr-Smith HD. Overestimation of serum free light chain concentration by immunonephelometry. Clin Chem 2010;56:1503-4.
15. Hutchison CA, Plant T, Drayson M, Cockwell P, Kountouri M, Basnayake K, et al. Serum free light chain measurement aids the diagnosis of myeloma in patients with severe renal failure. BMC Nephrol 2008;9:11.
16. Nakano T, Nagata A. ELISAs for free human immunoglobulin light chains in serum: improvement of assay specifi city by using two specifi c antibodies in a sandwich detection method. J Immunol Methods 2004;293: 183-9. (Pubitemid 39468342)
17. Davern S, Tang LX, Williams TK, Macy SD, Wall JS, Weiss DT, et al. Immunodiagnostic capabilities of anti-free immunoglobulin light chain monoclonal antibodies. Am J Clin Pathol 2008;130:702-11.
18. Abe M, Goto T, Kennel SJ, Wolfenbarger D, Macy SD, Weiss DT, et al. Production and immunodiagnostic applications of antihuman light chain monoclonal antibodies. Am J Clin Pathol 1993;100:67-74. (Pubitemid 23213420)